Recent discussions on X about Franco-Nevada Corporation (FNV) have centered around the company's strong financial performance and strategic moves in the gold royalty and streaming sector. Many users have highlighted the company's impressive revenue generation with a lean operational structure, as well as its high profit margins and minimal capital expenses. There’s a notable buzz around the potential revenue boost from key projects, which could further solidify its position in the market.
Additionally, posts on X reflect optimism about Franco-Nevada’s guidance for 2025, especially with gold prices surpassing earlier projections, fueling expectations of robust earnings. Some discussions also point to the company’s plans to expand its royalty and streaming business in regions like Australia, driven by record-high gold prices. The tone on the platform suggests a growing interest in how these developments could impact the stock’s trajectory.
Note: This discussion summary was generated from an AI condensation of post data.
Franco-Nevada Corporation Congressional Stock Trading
Members of Congress have traded $FNV stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $FNV stock by members of Congress over the last 6 months:
- REPRESENTATIVE THOMAS H. KEAN, JR. purchased up to $15,000 on 09/03.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Franco-Nevada Corporation Hedge Fund Activity
We have seen 256 institutional investors add shares of Franco-Nevada Corporation stock to their portfolio, and 221 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ removed 2,043,929 shares (-58.0%) from their portfolio in Q2 2025, for an estimated $335,040,841
- FMR LLC added 1,109,317 shares (+9.2%) to their portfolio in Q2 2025, for an estimated $181,839,242
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 838,853 shares (+35.2%) to their portfolio in Q2 2025, for an estimated $137,504,783
- NORGES BANK added 776,500 shares (+38.3%) to their portfolio in Q2 2025, for an estimated $127,283,879
- VICTORY CAPITAL MANAGEMENT INC removed 705,430 shares (-27.8%) from their portfolio in Q2 2025, for an estimated $115,634,085
- CAPITAL RESEARCH GLOBAL INVESTORS added 633,035 shares (+inf%) to their portfolio in Q2 2025, for an estimated $103,767,097
- ALBERTA INVESTMENT MANAGEMENT CORP removed 512,671 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $84,037,030
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Franco-Nevada Corporation Analyst Ratings
Wall Street analysts have issued reports on $FNV in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Raymond James issued a "Outperform" rating on 10/10/2025
- CIBC issued a "Outperformer" rating on 10/10/2025
- HC Wainwright & Co. issued a "Buy" rating on 08/12/2025
- UBS issued a "Buy" rating on 07/03/2025
To track analyst ratings and price targets for Franco-Nevada Corporation, check out Quiver Quantitative's $FNV forecast page.
Franco-Nevada Corporation Price Targets
Multiple analysts have issued price targets for $FNV recently. We have seen 8 analysts offer price targets for $FNV in the last 6 months, with a median target of $217.0.
Here are some recent targets:
- Cosmos Chiu from CIBC set a target price of $460.0 on 10/10/2025
- Craig Stanley from Raymond James set a target price of $234.0 on 10/10/2025
- Carey Macrury from Canaccord Genuity set a target price of $322.0 on 10/02/2025
- Daniel Major from UBS set a target price of $250.0 on 09/19/2025
- Heiko F. Ihle from HC Wainwright & Co. set a target price of $200.0 on 08/12/2025
- Tanya Jakusconek from Scotiabank set a target price of $184.0 on 08/12/2025
- Derick Ma from TD Securities set a target price of $184.0 on 08/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
